Literature DB >> 22516402

Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent.

Lakshmana K Pendyala1, Daisuke Matsumoto, Toshiro Shinke, Taizo Iwasaki, Ryota Sugimoto, Dongming Hou, Jack P Chen, Jaipal Singh, Spencer B King, Nicolas Chronos, Jinsheng Li.   

Abstract

OBJECTIVES: The current study sought to examine inflammation at the stented segments of Nobori (Terumo Corporation, Tokyo, Japan) and Cypher (Cordis, Miami, Florida) drug-eluting stents (DES), as well as free radical production and endothelial function of the adjacent nonstented segments in a pig coronary model.
BACKGROUND: Nobori is a novel DES, incorporating a biolimus A9-eluting biodegradable polymer coated only on the abluminal surface of the stent. These unique features may favorably affect inflammation and endothelial function, as compared to the currently marketed DES. Presently, pre-clinical data on direct comparison of the various generations of DES are not available.
METHODS: A total of 18 DES were implanted in pig coronary arteries and subsequently explanted at 1 month. Stented segments were assessed by angiography and histology. Ex vivo vasomotor function and superoxide production in segments proximal and distal to the stent were determined. The vasoconstriction, endothelial-dependent relaxation, and endothelial-independent relaxation of proximal and distal nonstented segments were measured.
RESULTS: Histological evaluation revealed lower inflammatory response with Nobori than with Cypher DES. There is trend for lower angiographic percentage diameter stenosis in Nobori versus Cypher groups (p = 0.054). There was increased endothelium-dependent relaxation, decreased endothelin-1-mediated contraction, and less superoxide production in the vessel segments proximal and distal to Nobori versus Cypher stents.
CONCLUSIONS: Our data show significantly lower inflammatory response in the stented segments, and rapid recovery of endothelial function of peristent segments in the Nobori group compared with Cypher DES group at 1 month in porcine coronary artery model.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22516402     DOI: 10.1016/j.jcin.2011.11.013

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  14 in total

1.  Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release.

Authors:  Celso Kiyochi Takimura; Carlos Augusto Homem M Campos; Pedro Henrique Magualhães Craveiro Melo; Julliana Carvalho Campos; Paulo Sampaio Gutierrez; Thiago Francisco Costa Borges; Luciano Curado; Spero Penha Morato; Francisco Rafael Martins Laurindo; Pedro Alves Lemos Neto
Journal:  Arq Bras Cardiol       Date:  2014-04-17       Impact factor: 2.000

2.  Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model.

Authors:  Masayuki Mori; Kenji Sakata; Chiaki Nakanishi; Takuya Nakahashi; Masa-Aki Kawashiri; Kazuaki Yoshioka; Yoh Takuwa; Hirofumi Okada; Jun-Ichiro Yokawa; Masaya Shimojima; Tsuyoshi Yoshimuta; Shohei Yoshida; Masakazu Yamagishi; Kenshi Hayashi
Journal:  Heart Vessels       Date:  2017-05-17       Impact factor: 2.037

Review 3.  Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention?

Authors:  Andrea Tryfonos; Daniel J Green; Ellen A Dawson
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

4.  Evaluation and medical therapy for coronary endothelial dysfunction induced by sirolimus-eluting stent in patient with an atherosclerotic lesion of the left main coronary artery: Case report.

Authors:  Hiroyuki Tabata; Satoshi Yoshino; Kenta Ohmure; Daichi Fukumoto; Hirokazu Shimono; Yoshihiro Uchikado; Shigeki Tateishi; Mitsuru Ohishi
Journal:  J Cardiol Cases       Date:  2017-09-22

Review 5.  Advances in nanotechnology for the management of coronary artery disease.

Authors:  June-Wha Rhee; Joseph C Wu
Journal:  Trends Cardiovasc Med       Date:  2012-12-13       Impact factor: 6.677

6.  State-of-the-Art Stent Technology to Minimize the Risk of Stent Thrombosis and In-Stent Restenosis: Abluminal-Coated Biodegradable Polymer Drug-Eluting Stent.

Authors:  Dong Oh Kang; Cheol Ung Choi
Journal:  Korean Circ J       Date:  2022-05       Impact factor: 3.101

7.  Histopathological background data of the systemic organs of CLAWN miniature swine with coronary artery stent implantation.

Authors:  Atsushi Isobe; Masako Tasaki; Tomoki Inoue; Hisako Terao; Junko Souba; Kasuke Nagano; Hitomi Hagiwara
Journal:  J Toxicol Pathol       Date:  2016-10-17       Impact factor: 1.628

Review 8.  Nanomedicine in coronary artery disease.

Authors:  Paurush Ambesh; Umberto Campia; Chukwudi Obiagwu; Rashika Bansal; Vijay Shetty; Gerald Hollander; Jacob Shani
Journal:  Indian Heart J       Date:  2017-02-24

9.  Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.

Authors:  Abhilash Akinapelli; Jack P Chen; Kristine Roy; Joseph Donnelly; Keith Dawkins; Barbara Huibregtse; Dongming Hou
Journal:  Curr Cardiol Rev       Date:  2017

Review 10.  Efficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis.

Authors:  Yicong Ye; Hongzhi Xie; Yong Zeng; Xiliang Zhao; Zhuang Tian; Shuyang Zhang
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.